##  [Novartis announces update to United States prescribing information for MS therapy Gilenya following FDA review ](/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review-0 "Novartis announces update to United States prescribing information for MS therapy Gilenya following FDA review  ") 

  Apr 20, 2012